Potential facet for prenatal arsenic exposure paradigm: linking endocrine disruption and epigenetics
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abhyankar LN, Jones MR, Guallar E, Navas-Acien A. Arsenic exposure and hypertension: a systematic review. Environ Health Perspect. 2012;120:494–500.
Ahir BK, Sanders AP, Rager JE, Fry RC. Systems biology and birth defects prevention: blockade of the glucocorticoid receptor prevents arsenic-induced birth defects. Environ Health Perspect. 2013;121:332–8.
Ahmad SA, Sayed MH, Barua S, Khan MH, Faruquee MH, Jalil A, et al. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect. 2001;109:629–31.
Allan AM, Hafez AK, Labrecque MT, Solomon ER, Shaikh MN, Zheng X, et al. Sex-dependent effects of developmental arsenic exposure on methylation capacity and methylation regulation of the glucocorticoid receptor system in the embryonic mouse brain. Toxicol Rep. 2015;2:1376–90.
Al-Eryani L, Jenkins SF, States VA, Pan J, Malone JC, Rai SN, et al. miRNA expression profiles of premalignant and malignant arsenic induced skin lesions. PLoS ONE. 2018;13(8):e0202579.
Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005;308:1466–9.
Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA. Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells. Reprod Sci. 2008;15:1011–7.
Bailey K, Fry RC. Long-term health consequences of prenatal arsenic exposure: links to the genome and the epigenome. Rev Environ Health. 2014;29:9–12.
Banik A, Kandilya D, Ramya S, Stünkel W, Chong YS, Dheen ST. Maternal factors that induce epigenetic changes contribute to neurological disorders in offspring. Genes. 2017;8(6):150.
Barouki R, Gluckman PD, Grandjean P, Hanson M, Heindel JJ. Developmental origins of non-communicable disease: implications for research and public health. Environ Health. 2012;11:42.
Beaver LM, Truong L, Barton CL, Chase TT, Gonnerman GD, Wong CP, et al. Combinatorial effects of zinc deficiency and arsenic exposure on zebrafish (Danio rerio) development. PLoS ONE. 2017;12(8):e0183831.
Bencko V. Carcinogenic, teratogenic, and mutagenic effects of arsenic. Environ Health Perspect. 1977;19:179–82.
Bodwell JE, Gosse JA, Nomikos AP, Hamilton JW. Arsenic disruption of steroid receptor gene activation: complex dose-response effects are shared by several steroid receptors. Chem Res Toxicol. 2006;19:1619–29.
Bodwell JE, Kingsley LA, Hamilton JW. Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. Chem Res Toxicol. 2004;17:1064–76.
Bommarito PA, Martin E, Fry RC. Effects of prenatal exposure to endocrine disruptors and toxic metals on the fetal epigenome. Epigenomics. 2017;9:333–50.
Bourguignon NS, Bonaventura MM, Rodriguez D, Bizzozzero M, Ventura C, Nunez M, et al. Evaluation of sodium arsenite exposure on reproductive competence in pregnant and postlactational dams and their offspring. Reprod Toxicol. 2017;69:1–12.
Broberg K, Ahmed S, Engstrom K, Hossain MB, Jurkovic Mlakar S, Bottai M, et al. Arsenic exposure in early pregnancy alters genome-wide DNA methylation in cord blood, particularly in boys. J Dev Orig Health Dis. 2014;5:288–98.
Caldwell KE, Labrecque MT, Solomon BR, Ali A, Allan AM. Prenatal arsenic exposure alters the programming of the glucocorticoid signaling system during embryonic development. Neurotoxicol Teratol. 2015;47:66–79.
Cardenas A, Houseman EA, Baccarelli AA, Quamruzzaman Q, Rahman M, Mostofa G, et al. In utero arsenic exposure and epigenome-wide associations in placenta, umbilical artery, and human umbilical vein endothelial cells. Epigenetics. 2015;10:1054–63.
Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics. 1997;45:607–17.
Carson R. Silent spring. Boston: Houghton-Mifflin; 1962.
Chatterjee A, Chatterji U. Arsenic abrogates the estrogen-signaling pathway in the rat uterus. Reprod Biol Endocrinol. 2010;8:80.
Chatterjee D, Bandyopadhyay A, Sarma N, Basu S, Roychowdhury T, Roy SS, Giri AK. Role of microRNAs in senescence and its contribution to peripheral neuropathy in the arsenic exposed population of West Bengal, India. Environ Pollut. 2018;233:596–603.
Chen GC, Guan LS, Hu WL, Wang ZY. Functional repression of estrogen receptor a by arsenic trioxide in human breast cancer cells. Anticancer Res. 2002;22:633–8.
Chen QY, DesMarais T, Costa M. Metals and mechanisms of carcinogenesis. Annu Rev Pharmacol Toxicol. 2019;59:537–54.
Cheung P, Lau P. Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol. 2005;19:563–73.
Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995;55:1296–300.
Chow SK, Chan JY, Fung KP. Suppression of cell proliferation and regulation of estrogen receptor alpha signaling pathway by arsenic trioxide on human breast cancer MCF-7 cells. J Endocrinol. 2004;182:325–37.
Cronican AA, Fitz NF, Carter A, Saleem M, Shiva S, Barchowsky A, et al. Genome-wide alteration of histone H3K9 acetylation pattern in mouse offspring prenatally exposed to arsenic. PLoS ONE. 2013;8:e53478.
Cruz-Topete D, Cidlowski JA. One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids. NeuroImmunoModulation. 2015;22:20–32.
Dakeishi M, Murata K, Grandjean P. Long-term consequences of arsenic poisoning during infancy due to contaminated milk powder. Environ Health. 2006;5:31.
Ditzel EJ, Nguyen T, Parker P, Camenisch TD. Effects of arsenite exposure during fetal development on energy metabolism and susceptibility to diet-induced fatty liver disease in male mice. Environ Health Perspect. 2016;124:201–9.
Dolinoy DC, Jirtle RL. Environmental epigenomics in human health and disease. Environ Mol Mutagen. 2008;49:4–8.
Dong X, Shulzhenko N, Lemaitre J, Greer RL, Peremyslova K, Quamruzzaman Q, et al. Arsenic exposure and intestinal microbiota in children from Sirajdikhan, Bangladesh. PLoS ONE. 2017;12(12):e0188487.
Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457–63.
Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH. Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev. 1994;16:184–209.
Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol. 2005;45:629–56.
Farzan SF, Korrick S, Li Z, Enelow R, Gandolfi AJ, Madan J, et al. In utero arsenic exposure and infant infection in a United States cohort: a prospective study. Environ Res. 2013;126:24–30.
Feldman RG, Niles CA, Kelly-Hayes M, Sax DS, Dixon WJ, Thompson DJ, et al. Peripheral neuropathy in arsenic smelter workers. Neurology. 1979;29:939–44.
Ferreira RT, Silva AR, Pimentel C, Batista-Nascimento L, Rodrigues-Pousada C, Menezes RA. Arsenic stress elicits cytosolic Ca(2 +) bursts and Crz1 activation in Saccharomyces cerevisiae. Microbiology. 2012;158:2293–302.
Flora S. Handbook of arsenic toxicology. Cambridge: Academic Press; 2015.
Geisler SJ, Paro R. Trithorax and Polycomb group-dependent regulation: a tale of opposing activities. Development. 2015;142:2876–87.
Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, et al. Activation of inflammation/NF-jB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 2007;3(11):e207.
Gliga AR, Engstrom K, Kippler M, Skroder H, Ahmed S, Vahter M, et al. Prenatal arsenic exposure is associated with increased plasma IGFBP3 concentrations in 9-year-old children partly via changes in DNA methylation. Arch Toxicol. 2018;92:2487–500.
Gluckman PD, Hanson MA, Mitchell MD. Developmental origins of health and disease: reducing the burden of chronic disease in the next generation. Genome Med. 2010;2:14.
Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD, Hanson MA. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res. 2007;61:5R–10R.
Goggin SL, Labrecque MT, Allan AM. Perinatal exposure to 50 ppb sodium arsenate induces hypothalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice. Neurotoxicology. 2012;33:1338–45.
Golub MS, Macintosh MS, Baumrind N. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J Toxicol Environ Health B Crit Rev. 1998;1:199–241.
Gonzalez-Cortes T, Recio-Vega R, Lantz RC, Chau BT. DNA methylation of extracellular matrix remodeling genes in children exposed to arsenic. Toxicol Appl Pharmacol. 2017;329:140–7.
Green BB, Karagas MR, Punshon T, Jackson BP, Robbins DJ, Houseman EA, et al. Epigenome-wide assessment of DNA methylation in the placenta and arsenic exposure in the new hampshire birth cohort study (USA). Environ Health Perspect. 2016;124:1253–60.
Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986;320:134–9.
Gundert-Remy U, Damm G, Foth H, Freyberger A, Gebel T, Golka K, et al. High exposure to inorganic arsenic by food: the need for risk reduction. Arch Toxicol. 2015;89:2219–27.
Hill DS, Wlodarczyk BJ, Mitchell LE, Finnell RH. Arsenate-induced maternal glucose intolerance and neural tube defects in a mouse model. Toxicol Appl Pharmacol. 2009;239:29–36.
Hoffmann F, Kloas W. An environmentally relevant endocrine-disrupting antiandrogen, vinclozolin, affects calling behavior of male Xenopus laevis. Horm Behav. 2010;58:653–9.
Hopenhayn-Rich C, Browning SR, Hertz-Picciotto I, Ferreccio C, Peralta C, Gibb H. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect. 2000;108:667–73.
Howe CG, Gamble MV. Influence of arsenic on global levels of histone posttranslational modifications: a review of the literature and challenges in the field. Curr Environ Health Rep. 2016;3:225–37.
Huang MC, Douillet C, Dover EN, Styblo M. Prenatal arsenic exposure and dietary folate and methylcobalamin supplementation alter the metabolic phenotype of C57BL/6 J mice in a sex-specific manner. Arch Toxicol. 2018;92:1925–37.
Huff MO, Todd SL, Smith AL, Elpers JT, Smith AP, Murphy RD, et al. Arsenite and cadmium activate MAPK/ERK via membrane estrogen receptors and G-protein coupled estrogen receptor signaling in human lung adenocarcinoma cells. Toxicol Sci. 2016;152:62–71.
Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 2011;123:305–32.
Intarasunanont P, Navasumrit P, Waraprasit S, Chaisatra K, Suk WA, Mahidol C, et al. Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ Health. 2012;11:31.
Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(Suppl):245–54.
Jaishankar M, Tseten T, Anbalagan N, Mathew BB, Beeregowda KN. Toxicity, mechanism and health effects of some heavy metals. Interdiscip Toxicol. 2014;7:60–72.
Karagas MR, Gossai A, Pierce B, Ahsan H. Drinking water arsenic contamination, skin lesions, and malignancies: a systematic review of the global evidence. Curr Environ Health Rep. 2015;2:52–68.
Kaushal A, Zhang H, Karmaus WJJ, Everson TM, Marsit CJ, Karagas MR, et al. Genome-wide DNA methylation at birth in relation to in utero arsenic exposure and the associated health in later life. Environ Health. 2017;16:50.
Kile ML, Baccarelli A, Hoffman E, Tarantini L, Quamruzzaman Q, Rahman M, et al. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect. 2012;120:1061–6.
Kile ML, Houseman EA, Baccarelli AA, Quamruzzaman Q, Rahman M, Mostofa G, et al. Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014;9:774–82.
Kim S, Takeuchi A, Kawasumi Y, Endo Y, Lee H, Kim Y. A Guillain-Barre syndrome-like neuropathy associated with arsenic exposure. J Occup Health. 2012;54:344–7.
Koestler DC, Avissar-Whiting M, Houseman EA, Karagas MR, Marsit CJ. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Environ Health Perspect. 2013;121:971–7.
Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 1996;93:5925–30.
Kumar S, Mukherjee TK, Guptasarma P. Arsenic and 17-beta-estradiol bind to each other and neutralize each other’s signaling effects. Biochem Biophys Res Commun. 2016;477:575–80.
Laine JE, Fry RC. A systems toxicology-based approach reveals biological pathways dysregulated by prenatal arsenic exposure. Ann Glob Health. 2016;82:189–96.
Law Smith MJ, Deady DK, Moore FR, Jones BC, Cornwell RE, Stirrat M, et al. Maternal tendencies in women are associated with estrogen levels and facial femininity. Horm Behav. 2012;61:12–6.
Lee MJ, Pramyothin P, Karastergiou K, Fried SK. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity. Biochim Biophys Acta. 2014;1842:473–81.
Li H, Engstrom K, Vahter M, Broberg K. Arsenic exposure through drinking water is associated with longer telomeres in peripheral blood. Chem Res Toxicol. 2012;25:2333–9.
Li X, Sun Z, Manthari RK, Li M, Guo Q, Wang J. Effect of gestational exposure to arsenic on puberty in offspring female mice. Chemosphere. 2018;202:119–26.
Li Y, Zhu H, Pan Y. Teratogenic effects of arsenic on rats. Zhonghua Yu Fang Yi Xue Za Zhi. 1998;32:37–9.
Liu H, Lu S, Zhang B, Xia W, Liu W, Peng Y, et al. Maternal arsenic exposure and birth outcomes: a birth cohort study in Wuhan, China. Environ Pollut. 2018;236:817–23.
Liu J, Xie Y, Ducharme DM, Shen J, Diwan BA, Merrick BA, et al. Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure. Environ Health Perspect. 2006;114:404–11.
Mallozzi M, Bordi G, Garo C, Caserta D. The effect of maternal exposure to endocrine disrupting chemicals on fetal and neonatal development: a review on the major concerns. Birth Defects Res C Embryo Today. 2016;108:224–42.
Martinez EJ, Kolb BL, Bell A, Savage DD, Allan AM. Moderate perinatal arsenic exposure alters neuroendocrine markers associated with depression and increases depressive-like behaviors in adult mouse offspring. Neurotoxicology. 2008;29:647–55.
Martinez L, Jimenez V, Garcia-Sepulveda C, Ceballos F, Delgado JM, Nino-Moreno P, et al. Impact of early developmental arsenic exposure on promotor CpG-island methylation of genes involved in neuronal plasticity. Neurochem Int. 2011;58:574–81.
Martinez-Finley EJ, Goggin SL, Labrecque MT, Allan AM. Reduced expression of MAPK/ERK genes in perinatal arsenic-exposed offspring induced by glucocorticoid receptor deficits. Neurotoxicol Teratol. 2011;33:530–7.
Martinez-Pacheco M, Hidalgo-Miranda A, Romero-Cordoba S, Valverde M, Rojas E. MRNA and miRNA expression patterns associated to pathways linked to metal mixture health effects. Gene. 2014;533:508–14.
Morris JS, Schmid M, Newman S, Scheuer PJ, Sherlock S. Arsenic and noncirrhotic portal hypertension. Gastroenterology. 1974;66:86–94.
Myers B, McKlveen JM, Herman JP. Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress. Front Neuroendocrinol. 2014;35:180–96.
Nadeau KC, Li Z, Farzan S, Koestler D, Robbins D, Fei DL, et al. In utero arsenic exposure and fetal immune repertoire in a US pregnancy cohort. Clin Immunol. 2014;155:188–97.
Nakareangrit W, Thiantanawat A, Visitnonthachai D, Watcharasit P, Satayavivad J. Sodium arsenite inhibited genomic estrogen signaling but induced pERalpha (Ser118) via MAPK pathway in breast cancer cells. Environ Toxicol. 2016;31:1133–46.
Ngalame NN, Micciche AF, Feil ME, States JC. Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. Toxicol Sci. 2013;131:225–33.
Nohara K, Okamura K, Suzuki T, Murai H, Ito T, Shinjo K, et al. Augmenting effects of gestational arsenite exposure of C3H mice on the hepatic tumors of the F(2) male offspring via the F(1) male offspring. J Appl Toxicol. 2016;36:105–12.
Painter RC, Roseboom TJ, Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol. 2005;20:345–52.
Pant HH, Rao MV. Evaluation of in vitro anti-genotoxic potential of melatonin against arsenic and fluoride in human blood cultures. Ecotoxicol Environ Saf. 2010;73:1333–7.
Parodi DA, Greenfield M, Evans C, Chichura A, Alpaugh A, Williams J, et al. Alteration of mammary gland development and gene expression by in utero exposure to arsenic. Reprod Toxicol. 2015;54:66–75.
Parvez F, Wasserman GA, Factor-Litvak P, Liu X, Slavkovich V, Siddique AB, et al. Arsenic exposure and motor function among children in Bangladesh. Environ Health Perspect. 2011;119:1665–70.
Paul S, Majumdar S, Giri AK. Genetic susceptibility to arsenic-induced skin lesions and health effects: a review. Genes Environ. 2015;37:23.
Phookphan P, Navasumrit P, Waraprasit S, Promvijit J, Chaisatra K, Ngaotepprutaram T, et al. Hypomethylation of inflammatory genes (COX2, EGR1, and SOCS3) and increased urinary 8-nitroguanine in arsenic-exposed newborns and children. Toxicol Appl Pharmacol. 2017;316:36–47.
Pilsner JR, Hall MN, Liu X, Ilievski V, Slavkovich V, Levy D, et al. Influence of prenatal arsenic exposure and newborn sex on global methylation of cord blood DNA. PLoS ONE. 2012;7:e37147.
Puzanova L, Doskocil M. Mechanism of the development of malformations in chick embryos after administration of arsenic (author’s transl). Sb Lek. 1976;78:57–63.
Quansah R, Armah FA, Essumang DK, Luginaah I, Clarke E, Marfoh K, et al. Association of arsenic with adverse pregnancy outcomes/infant mortality: a systematic review and meta-analysis. Environ Health Perspect. 2015;123:412–21.
Rager JE, Bailey KA, Smeester L, Miller SK, Parker JS, Laine JE, et al. Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood. Environ Mol Mutagen. 2014;55:196–208.
Rager JE, Yosim A, Fry RC. Prenatal exposure to arsenic and cadmium impacts infectious disease-related genes within the glucocorticoid receptor signal transduction pathway. Int J Mol Sci. 2014;15:22374–91.
Rahman A, Vahter M, Ekstrom EC, Persson LA. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect. 2011;119:719–24.
Rakyan VK, Chong S, Champ ME, Cuthbert PC, Morgan HD, Luu KV, et al. Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele occurs after maternal and paternal transmission. Proc Natl Acad Sci USA. 2003;100:2538–43.
Ramsey KA, Foong RE, Sly PD, Larcombe AN, Zosky GR. Early life arsenic exposure and acute and long-term responses to influenza A infection in mice. Environ Health Perspect. 2013;121:1187–93.
Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, et al. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett. 2009;185:197–202.
Reichard JF, Puga A. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics. 2010;2:87–104.
Rios R, Zarazua S, Santoyo ME, Sepulveda-Saavedra J, Romero-Diaz V, Jimenez V, et al. Decreased nitric oxide markers and morphological changes in the brain of arsenic-exposed rats. Toxicology. 2009;261:68–75.
Rojas D, Rager JE, Smeester L, Bailey KA, Drobna Z, Rubio-Andrade M, et al. Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015;143:97–106.
Sage AP, Minatel BC, Ng KW, Stewart GL, Dummer TJB, Lam WL, Martinez VD. Oncogenomic disruptions in arsenic-induced carcinogenesis. Oncotarget. 2017;8:25736–55.
Saha KK, Engstrom A, Hamadani JD, Tofail F, Rasmussen KM, Vahter M. Pre- and postnatal arsenic exposure and body size to 2 years of age: a cohort study in rural Bangladesh. Environ Health Perspect. 2012;120:1208–14.
Shen J, Liu J, Xie Y, Diwan BA, Waalkes MP. Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. Toxicol Sci. 2007;95:313–20.
Shi H, Shi X, Liu KJ. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem. 2004;255:67–78.
Stafford DE. Altered hypothalamic-pituitary-ovarian axis function in young female athletes: implications and recommendations for management. Treat Endocrinol. 2005;4:147–54.
States JC, Srivastava S, Chen Y, Barchowsky A. Arsenic and cardiovascular disease. Toxicol Sci. 2009;107:312–23.
States JC, Singh AV, Knudsen TB, Rouchka EC, Ngalame NO, Arteel GE, et al. Prenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosis. PLoS ONE. 2012;7:e38713.
Steinmaus C, Ferreccio C, Acevedo J, Balmes JR, Liaw J, Troncoso P, et al. High risks of lung disease associated with early-life and moderate lifetime arsenic exposure in northern Chile. Toxicol Appl Pharmacol. 2016;313:10–5.
Steinmaus C, Ferreccio C, Yuan Y, Acevedo J, Gonzalez F, Perez L, et al. Elevated lung cancer in younger adults and low concentrations of arsenic in water. Am J Epidemiol. 2014;180:1082–7.
Szymkowicz DB, Sims KC, Castro NM, Bridges WC, Bain LJ. Embryonic-only arsenic exposure in killifish (Fundulus heteroclitus) reduces growth and alters muscle IGF levels one year later. Aquat Toxicol. 2017;186:1–10.
Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Exs. 2012;101:133–64.
Tokar EJ, Diwan BA, Thomas DJ, Waalkes MP. Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice. Arch Toxicol. 2012;86:975–82.
Tsuji JS, Perez V, Garry MR, Alexander DD. Association of low-level arsenic exposure in drinking water with cardiovascular disease: a systematic review and risk assessment. Toxicology. 2014;323:78–94.
Tyler CR, Allan AM. Adult hippocampal neurogenesis and mRNA expression are altered by perinatal arsenic exposure in mice and restored by brief exposure to enrichment. PLoS ONE. 2013;8:e73720.
Tyler CR, Allan AM. The effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: a review. Curr Environ Health Rep. 2014;1:132–47.
Tyler CR, Hafez AK, Solomon ER, Allan AM. Developmental exposure to 50 parts-per-billion arsenic influences histone modifications and associated epigenetic machinery in a region- and sex-specific manner in the adult mouse brain. Toxicol Appl Pharmacol. 2015;288:40–51.
Tyler CR, Labrecque MT, Solomon ER, Guo X, Allan AM. Prenatal arsenic exposure alters REST/NRSF and microRNA regulators of embryonic neural stem cell fate in a sex-dependent manner. Neurotoxicol Teratol. 2017;59:1–15.
Tyler CR, Weber JA, Labrecque M, Hessinger JM, Edwards JS, Allan AM. ChIP-Seq analysis of the adult male mouse brain after developmental exposure to arsenic. Data Brief. 2015;5:248–54.
Tyler CRS, Smoake JJW, Solomon ER, Villicana E, Caldwell KK, Allan AM. Sex-dependent effects of the histone deacetylase inhibitor, sodium valproate, on reversal learning after developmental arsenic exposure. Front Genet. 2018;9:200.
Waalkes MP, Liu J, Chen H, Xie Y, Achanzar WE, Zhou YS, et al. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst. 2004;96:466–74.
Waalkes MP, Liu J, Diwan BA. Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol. 2007;222:271–80.
Waalkes MP, Liu J, Ward JM, Powell DA, Diwan BA. Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res. 2006;66:1337–45.
Waalkes MP, Qu W, Tokar EJ, Kissling GE, Dixon D. Lung tumors in mice induced by “whole-life” inorganic arsenic exposure at human-relevant doses. Arch Toxicol. 2014;88:1619–29.
Wang W, Cheng S, Zhang D. Association of inorganic arsenic exposure with liver cancer mortality: a meta-analysis. Environ Res. 2014;135:120–5.
Wang W, Xie Z, Lin Y, Zhang D. Association of inorganic arsenic exposure with type 2 diabetes mellitus: a meta-analysis. J Epidemiol Community Health. 2014;68:176–84.
Wang Z, Yang C. Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: a novel mechanism of metal carcinogenesis. Semin Cancer Biol. 2019. https://doi.org/10.1016/j.semcancer.2019.01.002 .
Whirledge S, Cidlowski JA. Glucocorticoids and reproduction: traffic control on the road to reproduction. Trends Endocrinol Metab. 2017;28:399–415.
Willhite CC, Ferm VH. Prenatal and developmental toxicology of arsenicals. Adv Exp Med Biol. 1984;177:205–28.
Xi S, Jin Y, Lv X, Sun G. Distribution and speciation of arsenic by transplacental and early life exposure to inorganic arsenic in offspring rats. Biol Trace Elem Res. 2010;134:84–97.
Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, et al. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology. 2007;236:7–15.